These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Unusually high seroprevalence of Borna disease virus in clade E human immunodeficiency virus type 1-infected patients with sexually transmitted diseases in Thailand.
    Author: Auwanit W, Ayuthaya PI, Nakaya T, Fujiwara S, Kurata T, Yamanishi K, Ikuta K.
    Journal: Clin Diagn Lab Immunol; 1996 Sep; 3(5):590-3. PubMed ID: 8877141.
    Abstract:
    The seroprevalence of Borna disease virus (BDV) in human immunodeficiency virus type 1-infected individuals in Thailand was examined by using recombinant BDV p24. A high (38 to 48%) rate of seroprevalence of BDV was observed in clade E-infected patients with sexually transmitted diseases, compared with those in clade E-infected prostitutes (8.3%), pregnant women (0%), clade B-infected intravenous-drug users (0%), and human immunodeficiency virus type 1-negative blood donors (1.9%). Borna disease virus (BDV) is a neurotropic, yet unclassified, nonsegmented, negative-sense, single-stranded RNA virus which naturally infects horses and sheep, and induces a disease characterized by a progressive meningoencephalopathy. It has been suggested that BDV, or a related agent, is associated with specific psychiatric disorders. Previous seroprevalence studies of HIV-1-infected individuals identified a BDV seroprevalence of 4-8% at the early stage of HIV-1 infection which grew to 13.9% in later stages. BDV may be more widespread than previously thought and possible reactivated in immunosuppressed patients. BDV seroprevalence in HIV-1-infected individuals in Thailand was examined using recombinant BDV p24. The rates of infection were 38-48% in clade E-infected patients with sexually transmitted diseases, 8.3% in clade E-infected prostitutes, 0% in pregnant women, 0% in clade B-infected IV drug users, and 1.9% in HIV-1-negative blood donors.
    [Abstract] [Full Text] [Related] [New Search]